The Advanced Direct 1-Step (AdD1S) is one of the most validated tools for the evaluation of Shutdown Dose Rate in complex fusion tokamak machines. The present work is built on the experience in analyzing tokamaks using prior versions of the code, where the activation analysis was limited to the first-step reactions. In the light of the neutron irradiation scenarios foreseen for fusion power reactors and the increasing importance of safety requirements, the possibility to treat the multi-step reactions introduced in the present version represents a novel and relevant development in the field. Moreover, a new Python library, PyD1S, has been developed to optimize the MCNP-FISPACT interface and data analysis. In this paper, the recent developments and the first applications are presented.
Progress in development of advanced D1S dynamic code for three-dimensional shutdown dose rate calculations / Mariano, G.; Flammini, D.; Fonnesu, N.; Moro, F.; Villari, R.. - In: FUSION ENGINEERING AND DESIGN. - ISSN 0920-3796. - 157:(2020), p. 111631. [10.1016/j.fusengdes.2020.111631]
Progress in development of advanced D1S dynamic code for three-dimensional shutdown dose rate calculations
Mariano G.;
2020
Abstract
The Advanced Direct 1-Step (AdD1S) is one of the most validated tools for the evaluation of Shutdown Dose Rate in complex fusion tokamak machines. The present work is built on the experience in analyzing tokamaks using prior versions of the code, where the activation analysis was limited to the first-step reactions. In the light of the neutron irradiation scenarios foreseen for fusion power reactors and the increasing importance of safety requirements, the possibility to treat the multi-step reactions introduced in the present version represents a novel and relevant development in the field. Moreover, a new Python library, PyD1S, has been developed to optimize the MCNP-FISPACT interface and data analysis. In this paper, the recent developments and the first applications are presented.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
